DCN ARCHIVES

September 8, 2004

Pfizer settles lawsuit

NEW YORK

Pfizer Inc. has agreed to pay $430 million (all funds U.S.) to settle all lawsuits against it alleging injury from insulation products made by a subsidiary, the firm reports.

Pfizer and its Quigley Co. subsidiary were named, along with several other defendants, in 171,611 lawsuits claiming personal injury caused by exposure to asbestos, silica or mixed dust.

Pfizer acquired Quigley Co. in 1968. It sold some products containing asbestos until the early 1970s.

Pfizer will establish a trust for the payment of pending claims as well as any future claims. It will contribute $405 million to the trust over 40 years through a note, and about $100 million in insurance. Pfizer will also forgive a $30-million loan to Quigley.

Quigley will file a reorganization plan that needs to be approved by the bankruptcy court and confirmed by a vote of 75 per cent of the claimants.

Pfizer will take a $229-million charge in the third quarter for the settlement.

Analysts polled by Thomson First Call had expected the company to earn $4.08 billion, or 54 cents a share, in the third quarter.

The Associated Press

Print | Comment

MOST POPULAR STORIES
TODAY’S TOP CONSTRUCTION PROJECTS

These projects have been selected from 443 projects with a total value of $1,866,277,015 that Reed Construction Data Building Reports reported on Tuesday.

APARTMENT BUILDINGS, OFFICES, RETAIL

$353,800,000 North York ON Prebid

HOTEL & AMUSEMENT PARK

$90,000,000 Niagara Falls ON Prebid

OFFICE BUILDINGS

$68,000,000 Oakville ON Prebid

Daily Top 10

CURRENT STORIES
ALEX’S ECONOMICS BLOG

Reed Construction Data Canada’s Chief Economist Alex Carrick discusses current developments in the North American economic environment with emphasis on the construction industry.

TODAY’S TOP JOBS

More jobs 

myJobsite.ca

Your gateway to
the top careers
in construction
and design